Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report

INTRODUCTION: Bevacizumab is a monoclonal antibody against vascular endothelial growth factor. It is widely used in the treatment of metastatic colorectal cancer. It has some specific side effects including severe bleeding, wound healing problems, gastrointestinal perforation, proteinuria and hypert...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Uysal, Mukremin, Goksu, Sema Sezgin, Coskun, Hasan Senol, Savas, Burhan, Ozdogan, Mustafa, Bozcuk, Hakan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2012
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3464779/
https://ncbi.nlm.nih.gov/pubmed/22776219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-6-188
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi